Invention Grant
- Patent Title: Antibody binding to human IL-1β, preparation method therefor and use thereof
-
Application No.: US17292384Application Date: 2019-11-04
-
Publication No.: US11976115B2Publication Date: 2024-05-07
- Inventor: Yu Xia , Zhongmin Wang , Peng Zhang , Baiyong Li
- Applicant: ZEDA BIOPHARMACEUTICALS, INC.
- Applicant Address: CN Shenzhen
- Assignee: ZEDA BIOPHARMACEUTICALS, INC.
- Current Assignee: ZEDA BIOPHARMACEUTICALS, INC.
- Current Assignee Address: CN Shenzhen
- Agency: Greer, Burns & Crain, Ltd.
- Agent Gregory P. Einhorn
- Priority: CN 1811322002.7 2018.11.07
- International Application: PCT/CN2019/115230 2019.11.04
- International Announcement: WO2020/093957A 2020.05.14
- Date entered country: 2021-05-07
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K39/395 ; A61P37/00 ; C12N5/10 ; C12N15/00 ; C12N15/13 ; A61K39/00 ; C12N5/00 ; C12N15/09 ; C12N15/63
Abstract:
Provided are antibodies or antigen binding fragments thereof, which can bind to human IL-1β, block the binding of IL-1β to receptors thereof and thereby down regulate the activity of IL-1β, and can be used to prepare drugs for the treatment of immune diseases mediated by IL-1β overexpression such as arthritis, osteoporosis, and tumor necrosis factor receptor-associated periodic syndrome.
Public/Granted literature
- US20220064282A1 ANTIBODY BINDING TO HUMAN IL-1 BETA, PREPARATION METHOD THEREFOR AND USE THEREOF Public/Granted day:2022-03-03
Information query
